Game-Changing
Biomolecule Synthesis
Developed in the same halls where CRISPR was created, CatenaBio’s technology enables the fusion of proteins with the 3-dimensional control that only previously existed with small molecule synthesis. The result is the ability to synthesize novel biomolecules in any structure, combination, or orientation—the only limitation is imagination.
We foresee the impact of our bioconjugation approach extending across therapeutic areas; it may even have consumer applications.
The core of CatenaBio’s technology results from an exhaustive search of the microbial kingdom for a robust enzyme with broad effectiveness. The patented Catenase™ technology enables biomolecules to be fused at naturally occurring amino acids—tyrosine and cysteine—under gentle reaction conditions that optimize novel biomolecule yield.
Originating From Berkeley Labs
Our science is invented by the top minds at UC Berkeley

Professor
Jennifer Doudna, PhD
Inventor | 2020 Nobel Prize Laureate – Chemistry

Professor
Matt Francis, PhD
Inventor | Chair of the UC Berkeley Department of Chemistry
Meet the Visionaries
Behind the Science
Leadership Team
Scientific Advisors

Matt Francis, PhD

John Delaney, PhD

Marc Lippman, MD
Board Members

Matt Francis, PhD

Marco Lobba, PhD

Chinmaya Rath
